GRFS News and Press, Grifols S.A. From 09/21/23

2023-09-21 13:56:01 ET Summary Grifols is a Spanish pharmaceutical company focused on blood plasma products, with a strong market position and an attractive growth pathway. The shares have underperformed peers and yielded negative returns over the last five years. We believe t...

2023-07-28 11:07:04 ET Grifols S.A. press release ( NASDAQ: GRFS ): 1H Adj EBITDA of Є655M. Revenue of Є3.23B (+14.8% Y/Y). Total revenue increases to EUR 3,225 million (+14.8%; +13.1% cc1 ) in the first six months of the year, driven by Biopharma F...

2023-07-27 15:45:16 ET Grifols, S.A. (GRFS) Q2 2023 Earnings Conference Call July 27, 2023, 08:30 AM ET Company Participants Nuria Pascual - IR Thomas Glanzmann - our Executive Chairman and CEO Alfredo Arroyo - CFO Victor Grifols Deu - COO Conference Ca...

2023-07-26 16:49:47 ET Grifols S.A. ( NASDAQ: GRFS ) is scheduled to announce Q2 earnings results on Thursday, July 27th, before market open. The consensus EPS Estimate is $0.15 and the consensus Revenue Estimate is $1.82B. For further details see: Grifols S.A. Q...

2023-07-26 11:31:10 ET Major earnings expected before the bell on Thursday include: AbbVie ( ABBV ) Bristol-Myers Squibb ( BMY ) Mastercard ( MA ) McDonald's ( MCD ) Shell ( SHEL ) For further details see: Notable earnings before Thursday'...

2023-07-05 10:56:31 ET Summary Grifols is a promising buy opportunity thanks to its potential to reduce its net debt/EBITDA ratio. The company's focus on deleveraging is showing results and is supported by higher savings and better margins. The plasma collection is also recovering...

2023-05-13 23:14:40 ET Summary I've reviewed Grifols once before and gave you my overall thesis on what I believe to be a solid pharma/biotech company. Investing in Spanish stocks without a dividend and worrying fundamentals is always a "thing" but I'll provide here why I have a s...

2023-05-09 22:36:06 ET Grifols, S.A. (GRFS) Q1 2023 Earnings Conference Call May 9, 2023 08:30 AM ET Company Participants Nuria Pascual - IR Thomas Glanzmann - Executive Chairman Victor Grifols Deu - Co-CEO Alfredo Arroyo - CFO Conference Call Participa...

2023-05-09 15:39:56 ET Shares of Grifols (NASDAQ: GRFS) were up 11.1% on Tuesday afternoon, after being up as much as 13.1% earlier in the day. The pharmaceutical company, which makes plasma-derived medicines, released first-quarter earnings on Tuesday morning. The stock is down...

2023-05-09 07:59:14 ET Grifols S.A. press release ( NASDAQ: GRFS ): Q1 Adjusted EBITDA margin improves to 21.0% (excl. Biotest) and Adjusted EBITDA increases 19% to €299 million, driven by operational leverage and cost discipline. Adjusted EBITDA guidance ...